ADMA Biologics, Inc. Share Price & Technical Analysis
ADMA · $8.24 (-2.60%)
Healthcare / Biotechnology
$8.24
-2.60%
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indica…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
-20% return in May, 17% avg return in past 3 year May month.
-64% return in 2026, 62% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -6% | -9% | -43% | 13% | -20% | – | – | – | – | – | – | – | -64% |
| 25 | -7% | 4% | 20% | 20% | -18% | -9% | 4% | -6% | -14% | 5% | 24% | -4% | 19% |
| 24 | 16% | 4% | 22% | -2% | 45% | 17% | 10% | 40% | 16% | -18% | 10% | -14% | 144% |
| 23 | -5% | -5% | -8% | 0% | 24% | -10% | 14% | -7% | -5% | -6% | 9% | 22% | 21% |
| 22 | 7% | 14% | 13% | 0% | 11% | -5% | 5% | 29% | -11% | 12% | 18% | 18% | 111% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.92B
P/E ratio
12.19
52W high
$22.37
52W low
$7.21
Volume
29,73,308
Beta
0.82
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is ADMA Biologics, Inc. share price today?
- ADMA Biologics, Inc. (ADMA) last traded around $8.24 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ADMA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ADMA. Download the app for real-time alerts.
- How can I analyze ADMA Biologics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.